MetaOptics has filed its draft prospectus to list on the Nasdaq on May 4 (US time).
The metalens firm, which listed on the Singapore Exchange’s (SGX) Catalist board in September 2025, said it was eyeing to dual-list on the US bourse in November 2025. In its announcement dated Nov 17, 2025, MetaOptics said the dual-listing will enable it to gain access to a diversified base of shareholders and investors. The company added that a Nasdaq listing will allow it to “build up its metalens design and fabrication capabilities in the US and to also position the group in close proximity to potential key customers”.
In its registration statement, the company says the net proceeds from its US listing will mainly support its expansion plans in the country.
For the FY2025 ended Dec 31, 2025, MetaOptics reported a deeper loss of $5.4 million from $2 million mainly due to the higher legal and professional fees incurred for its initial public offering (IPO). Revenue for the year surged by 891% y-o-y to $787,388 mainly due to higher sales of equipment from a customer’s direct laser writer (DLW) order, as well as higher sales of metalens products and equipment installation services.
Roth Capital Partners and Benchmark are the joint book-running managers.
As at 10.21am, shares in MetaOptics are trading 1 cent higher or 1.07% up at 94.5 cents.
